|
[1]
|
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263.
https://doi.org/10.3322/caac.21834
|
|
[2]
|
Siegel, R.L., Kratzer, T.B., Giaquinto, A.N., Sung, H. and Jemal, A. (2025) Cancer Statistics, 2025. CA: A Cancer Journal for Clinicians, 75, 10-45.
https://doi.org/10.3322/caac.21871
|
|
[3]
|
Kim, J., Harper, A., McCormack, V., Sung, H., Houssami, N., Morgan, E., et al. (2025) Global Patterns and Trends in Breast Cancer Incidence and Mortality across 185 Countries. Nature Medicine, 31, 1154-1162.
https://doi.org/10.1038/s41591-025-03502-3
|
|
[4]
|
Swain, S.M., Shastry, M. and Hamilton, E. (2022) Targeting HER2-Positive Breast Cancer: Advances and Future Directions. Nature Reviews Drug Discovery, 22, 101-126.
https://doi.org/10.1038/s41573-022-00579-0
|
|
[5]
|
Gianni, L., Pienkowski, T., Im, Y.H., Tseng, L.M., Liu, M.C., Lluch, A., et al. (2016) 5-Year Analysis of Neoadjuvant Pertuzumab and Trastuzumab in Patients with Locally Advanced, Inflammatory, or Early-Stage HER2-Positive Breast Cancer (NeoSphere): A Multicentre, Open-Label, Phase 2 Randomised Trial. The Lancet Oncology, 17, 791-800.
https://doi.org/10.1016/s1470-2045(16)00163-7
|
|
[6]
|
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)乳腺癌诊疗指南[M]. 北京: 人民卫生出版社, 2025.
|
|
[7]
|
Balough, E., Ariza, A., Asnani, A. and Hoeger, C.W. (2025) Cardiotoxicity of Anthracyclines. Cardiology Clinics, 43, 111-127.
https://doi.org/10.1016/j.ccl.2024.08.002
|
|
[8]
|
Shao, Z., Pang, D., Yang, H., Li, W., Wang, S., Cui, S., et al. (2020) Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients with Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial. JAMA Oncology, 6, e193692.
https://doi.org/10.1001/jamaoncol.2019.3692
|
|
[9]
|
Huang, L., Pang, D., Yang, H., Li, W., Wang, S., Cui, S., et al. (2024) Neoadjuvant-Adjuvant Pertuzumab in HER2-Positive Early Breast Cancer: Final Analysis of the Randomized Phase III PEONY Trial. Nature Communications, 15, Article No. 2153.
https://doi.org/10.1038/s41467-024-45591-7
|
|
[10]
|
Lyon, A.R., López-Fernández, T., Couch, L.S., Asteggiano, R., Aznar, M.C., Bergler-Klein, J., et al. (2022) 2022 ESC Guidelines on Cardio-Oncology Developed in Collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal, 43, 4229-4361.
https://doi.org/10.1093/eurheartj/ehac244
|
|
[11]
|
López-Fernández, T., Marco, I., Aznar, M.C., Barac, A., Bergler-Klein, J., Meattini, I., et al. (2024) Breast Cancer and Cardiovascular Health. European Heart Journal, 45, 4366-4382.
https://doi.org/10.1093/eurheartj/ehae637
|
|
[12]
|
Curigliano, G., Cardinale, D., Dent, S., Criscitiello, C., Aseyev, O., Lenihan, D., et al. (2016) Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management. CA: A Cancer Journal for Clinicians, 66, 309-325.
https://doi.org/10.3322/caac.21341
|
|
[13]
|
Lyon, A.R., Dent, S., Stanway, S., Earl, H., Brezden-Masley, C., Cohen-Solal, A., et al. (2020) Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society. European Journal of Heart Failure, 22, 1945-1960.
https://doi.org/10.1002/ejhf.1920
|
|
[14]
|
Battisti, N.M.L., Andres, M.S., Lee, K.A., Ramalingam, S., Nash, T., Mappouridou, S., et al. (2021) Incidence of Cardiotoxicity and Validation of the Heart Failure Association-International Cardio-Oncology Society Risk Stratification Tool in Patients Treated with Trastuzumab for HER2-Positive Early Breast Cancer. Breast Cancer Research and Treatment, 188, 149-163.
https://doi.org/10.1007/s10549-021-06192-w
|
|
[15]
|
Čelutkienė, J., Pudil, R., López-Fernández, T., Grapsa, J., Nihoyannopoulos, P., Bergler-Klein, J., et al. (2020) Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). European Journal of Heart Failure, 22, 1504-1524.
https://doi.org/10.1002/ejhf.1957
|
|
[16]
|
Keramida, K. and Farmakis, D. (2021) Right Ventricular Involvement in Cancer Therapy-Related Cardiotoxicity: The Emerging Role of Strain Echocardiography. Heart Failure Reviews, 26, 1189-1193.
https://doi.org/10.1007/s10741-020-09938-8
|
|
[17]
|
Calleja, A., Poulin, F., Khorolsky, C., Shariat, M., Bedard, P.L., Amir, E., et al. (2015) Right Ventricular Dysfunction in Patients Experiencing Cardiotoxicity during Breast Cancer Therapy. Journal of Oncology, 2015, Article ID: 609194.
https://doi.org/10.1155/2015/609194
|
|
[18]
|
Voigt, J.U., Pedrizzetti, G., Lysyansky, P., Marwick, T.H., Houle, H., Baumann, R., et al. (2015) Definitions for a Common Standard for 2D Speckle Tracking Echocardiography: Consensus Document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging. European Heart Journal-Cardiovascular Imaging, 16, 1-11.
https://doi.org/10.1093/ehjci/jeu184
|
|
[19]
|
Badano, L.P., Kolias, T.J., Muraru, D., Abraham, T.P., Aurigemma, G., Edvardsen, T., et al. (2018) Standardization of Left Atrial, Right Ventricular, and Right Atrial Deformation Imaging Using Two-Dimensional Speckle Tracking Echocardiography: A Consensus Document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging. European Heart Journal—Cardiovascular Imaging, 19, 591-600.
https://doi.org/10.1093/ehjci/jey042
|
|
[20]
|
Lang, R.M., Badano, L.P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., et al. (2015) Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal-Cardiovascular Imaging, 16, 233-271.
https://doi.org/10.1093/ehjci/jev014
|
|
[21]
|
Genovese, D., Rashedi, N., Weinert, L., Narang, A., Addetia, K., Patel, A.R., et al. (2019) Machine Learning-based Three-Dimensional Echocardiographic Quantification of Right Ventricular Size and Function: Validation against Cardiac Magnetic Resonance. Journal of the American Society of Echocardiography, 32, 969-977.
https://doi.org/10.1016/j.echo.2019.04.001
|
|
[22]
|
Surkova, E., Cosyns, B., Gerber, B., Gimelli, A., La Gerche, A. and Ajmone Marsan, N. (2022) The Dysfunctional Right Ventricle: The Importance of Multi-Modality Imaging. European Heart Journal—Cardiovascular Imaging, 23, 885-897.
https://doi.org/10.1093/ehjci/jeac037
|
|
[23]
|
Odiete, O., Hill, M.F. and Sawyer, D.B. (2012) Neuregulin in Cardiovascular Development and Disease. Circulation Research, 111, 1376-1385.
https://doi.org/10.1161/circresaha.112.267286
|
|
[24]
|
Sandoo, A., Kitas, G.D. and Carmichael, A.R. (2015) Breast Cancer Therapy and Cardiovascular Risk: Focus on Trastuzumab. Vascular Health and Risk Management, 11, 223-228.
https://doi.org/10.2147/vhrm.s69641
|
|
[25]
|
Chen, Z.I. and Ai, D.I. (2016) Cardiotoxicity Associated with Targeted Cancer Therapies. Molecular and Clinical Oncology, 4, 675-681.
https://doi.org/10.3892/mco.2016.800
|
|
[26]
|
van Ramshorst, M.S., van der Voort, A., van Werkhoven, E.D., Mandjes, I.A., Kemper, I., Dezentjé, V.O., et al. (2018) Neoadjuvant Chemotherapy with or without Anthracyclines in the Presence of Dual HER2 Blockade for HER2-Positive Breast Cancer (TRAIN-2): A Multicentre, Open-Label, Randomised, Phase 3 Trial. The Lancet Oncology, 19, 1630-1640.
https://doi.org/10.1016/s1470-2045(18)30570-9
|
|
[27]
|
van der Voort, A., van Ramshorst, M.S., van Werkhoven, E.D., Mandjes, I.A., Kemper, I., Vulink, A.J., et al. (2021) Three-Year Follow-Up of Neoadjuvant Chemotherapy with or without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients with ERBB2-Positive Breast Cancer: A Secondary Analysis of the TRAIN-2 Randomized, Phase 3 Trial. JAMA Oncology, 7, 978-984.
https://doi.org/10.1001/jamaoncol.2021.1371
|
|
[28]
|
Surkova, E., Kovács, A., Tokodi, M., Lakatos, B.K., Merkely, B., Muraru, D., et al. (2021) Contraction Patterns of the Right Ventricle Associated with Different Degrees of Left Ventricular Systolic Dysfunction. Circulation: Cardiovascular Imaging, 14, e012774.
https://doi.org/10.1161/circimaging.121.012774
|
|
[29]
|
Muraru, D., Haugaa, K., Donal, E., Stankovic, I., Voigt, J.U., Petersen, S.E., et al. (2022) Right Ventricular Longitudinal Strain in the Clinical Routine: A State-of-the-Art Review. European Heart Journal—Cardiovascular Imaging, 23, 898-912.
https://doi.org/10.1093/ehjci/jeac022
|
|
[30]
|
Haroun, E., Agrawal, A., El Dahdah, J., Dong, T., Arockiam, A.D., Majid, M., et al. (2025) Right Ventricular Systolic Strain Reference Ranges across Contemporary Vendor-Neutral Echocardiography Software in Healthy Patients. JACC: Cardiovascular Imaging, 18, 122-124.
https://doi.org/10.1016/j.jcmg.2024.08.008
|
|
[31]
|
Keramida, K., Farmakis, D., Rakisheva, A., Tocchetti, C.G., Ameri, P., Asteggiano, R., et al. (2024) The Right Heart in Patients with Cancer. a Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. European Journal of Heart Failure, 26, 2077-2093.
https://doi.org/10.1002/ejhf.3412
|
|
[32]
|
Xu, H., Mao, L., Liu, H., Zhang, Y. and Yang, J. (2021) Assessment of Subclinical Deterioration of Right Ventricular Function by Three-Dimensional Speckle Tracking Echocardiography in Breast Cancer Patients Undergoing Anthracycline-Based Chemotherapy. International Journal of General Medicine, 14, 885-893.
https://doi.org/10.2147/ijgm.s300257
|
|
[33]
|
Li, Y., Zhang, L., Gao, Y., Wan, X., Xiao, Q., Zhang, Y., et al. (2021) Comprehensive Assessment of Right Ventricular Function by Three-Dimensional Speckle-Tracking Echocardiography: Comparisons with Cardiac Magnetic Resonance Imaging. Journal of the American Society of Echocardiography, 34, 472-482.
https://doi.org/10.1016/j.echo.2020.12.013
|
|
[34]
|
Tokodi, M., Staub, L., Budai, Á., Lakatos, B.K., Csákvári, M., Suhai, F.I., et al. (2021) Partitioning the Right Ventricle into 15 Segments and Decomposing Its Motion Using 3D Echocardiography-Based Models: The Updated Revision Method. Frontiers in Cardiovascular Medicine, 8, Article ID: 622118.
https://doi.org/10.3389/fcvm.2021.622118
|
|
[35]
|
Manganaro, R., Marchetta, S., Dulgheru, R., Ilardi, F., Sugimoto, T., Robinet, S., et al. (2019) Echocardiographic Reference Ranges for Normal Non-Invasive Myocardial Work Indices: Results from the EACVI NORRE Study. European Heart Journal—Cardiovascular Imaging, 20, 582-590.
https://doi.org/10.1093/ehjci/jey188
|
|
[36]
|
Russell, K., Eriksen, M., Aaberge, L., Wilhelmsen, N., Skulstad, H., Remme, E.W., et al. (2012) A Novel Clinical Method for Quantification of Regional Left Ventricular Pressure-strain Loop Area: A Non-Invasive Index of Myocardial Work. European Heart Journal, 33, 724-733.
https://doi.org/10.1093/eurheartj/ehs016
|
|
[37]
|
Butcher, S.C., Fortuni, F., Montero-Cabezas, J.M., Abou, R., El Mahdiui, M., van der Bijl, P., et al. (2021) Right Ventricular Myocardial Work: Proof-of-Concept for Non-Invasive Assessment of Right Ventricular Function. European Heart Journal—Cardiovascular Imaging, 22, 142-152.
https://doi.org/10.1093/ehjci/jeaa261
|
|
[38]
|
Lakatos, B.K., Rako, Z., Szijártó, Á., da Rocha, B.R.B., Richter, M.J., Fábián, A., et al. (2024) Right Ventricular Pressure-Strain Relationship-Derived Myocardial Work Reflects Contractility: Validation with Invasive Pressure-Volume Analysis. The Journal of Heart and Lung Transplantation, 43, 1183-1187.
https://doi.org/10.1016/j.healun.2024.03.007
|
|
[39]
|
Akiyama, K., Nakamura, N., Itatani, K., Naito, Y., Kinoshita, M., Shimizu, M., et al. (2017) Flow-Dynamics Assessment of Mitral-Valve Surgery by Intraoperative Vector Flow Mapping. Interactive CardioVascular and Thoracic Surgery, 24, 869-875.
https://doi.org/10.1093/icvts/ivx033
|
|
[40]
|
Chan, J.S.K., Lau, D.H.H., Fan, Y. and Lee, A.P. (2023) Fragmented Vortex in Heart Failure with Reduced Ejection Fraction: A Prospective Vector Flow Mapping Study. Ultrasound in Medicine & Biology, 49, 982-988.
https://doi.org/10.1016/j.ultrasmedbio.2022.12.001
|
|
[41]
|
Ghorbani, A., Ouyang, D., Abid, A., He, B., Chen, J.H., Harrington, R.A., et al. (2020) Deep Learning Interpretation of Echocardiograms. NPJ Digital Medicine, 3, Article No. 10.
https://doi.org/10.1038/s41746-019-0216-8
|
|
[42]
|
Tokodi, M., Magyar, B., Soós, A., Takeuchi, M., Tolvaj, M., Lakatos, B.K., et al. (2023) Deep Learning-Based Prediction of Right Ventricular Ejection Fraction Using 2D Echocardiograms. JACC: Cardiovascular Imaging, 16, 1005-1018.
https://doi.org/10.1016/j.jcmg.2023.02.017
|
|
[43]
|
Ouyang, D., He, B., Ghorbani, A., Yuan, N., Ebinger, J., Langlotz, C.P., et al. (2020) Video-Based AI for Beat-to-Beat Assessment of Cardiac Function. Nature, 580, 252-256.
https://doi.org/10.1038/s41586-020-2145-8
|
|
[44]
|
Plana, J.C., Galderisi, M., Barac, A., Ewer, M.S., Ky, B., Scherrer-Crosbie, M., et al. (2014) Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 27, 911-939.
https://doi.org/10.1016/j.echo.2014.07.012
|
|
[45]
|
Talebi, A., Bitarafan‐Rajabi, A., Alizadeh‐Asl, A., Seilani, P., Khajetash, B., Hajianfar, G., et al. (2025) Machine Learning Based Radiomics Model to Predict Radiotherapy Induced Cardiotoxicity in Breast Cancer. Journal of Applied Clinical Medical Physics, 26, e14614.
https://doi.org/10.1002/acm2.14614
|
|
[46]
|
Negishi, T., Thavendiranathan, P., Penicka, M., Lemieux, J., Murbraech, K., Miyazaki, S., et al. (2023) Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial. JACC: Cardiovascular Imaging, 16, 269-278.
https://doi.org/10.1016/j.jcmg.2022.10.010
|